A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Clinical trial NCT06226883 · RECRUITING
Trial details
- NCT number
- NCT06226883
- Sponsor
- Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-18
- Primary completion
- 2028-09-01
- Enrollment
- 385
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.